Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center.
Journal: JCO precision oncology
Published: February 24, 2022
Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer.
Journal: Cancer gene therapy
Published: April 30, 2021
Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a Methionine.
Journal: Journal of medicinal chemistry
Published: August 31, 2018
RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
Journal: Biochemical and biophysical research communications
Published: May 12, 2016
Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes.
Journal: Data in brief
Published: January 28, 2016
RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease.
Journal: Atherosclerosis
Published: May 21, 2015
Progression of degenerative mitral stenosis: insights from a cohort of 254 patients.
Journal: The Journal of heart valve disease
Published: March 21, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026